CGGBP1 regulates cell cycle in cancer cells

BMC Molecular Biology

Volumn 12, Issue , 2011, Pages

  Singh, Umashankar ^a   Roswall, Pernilla ^b   Uhrbom, Lene ^a   Westermark, Bengt ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5' (CGG)(N) 3' BINDING PROTEIN 1; ARF PROTEIN; BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2A; GROWTH ARREST SPECIFIC 1 PROTEIN; HISTONE H3; LYSINE DERIVATIVE; PROTEIN P53; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CGGBP1 PROTEIN, HUMAN; DNA BINDING PROTEIN; GAS1 PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN;

ABSCISSION; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL KINETICS; CELL POPULATION; CONTROLLED STUDY; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC ASSOCIATION; GLIOMA; HISTONE METHYLATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROMOTER REGION; REGULATOR GENE; RNA INTERFERENCE; ANIMAL; CELL CYCLE; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; TUMOR CELL CULTURE; TUMOR CELL LINE;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; G0 PHASE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HUMANS; MICE; NEOPLASMS; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; S PHASE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79959995023     PISSN: None     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-12-28     Document Type: Article

References (33)

1. Naumann F, Remus R, Schmitz B, Doerfler W. Gene structure and expression of the 5'-(CGG)(n)-3'-binding protein (CGGBP1). Genomics 2004, 83(1):106-118. 10.1016/S0888-7543(03)00212-X, 14667814.
2. Muller-Hartmann H, Deissler H, Naumann F, Schmitz B, Schroer J, Doerfler W. The human 20-kDa 5'-(CGG)(n)-3'-binding protein is targeted to the nucleus and affects the activity of the FMR1 promoter. J Biol Chem 2000, 275(9):6447-6452. 10.1074/jbc.275.9.6447, 10692448.
3. Singh U, Bongcam-Rudloff E, Westermark B. A DNA sequence directed mutual transcription regulation of HSF1 and NFIX involves novel heat sensitive protein interactions. PLoS One 2009, 4(4):e5050. 10.1371/journal.pone.0005050, 2660424, 19337383.
4. Singh U, Westermark B. CGGBP1 is a nuclear and midbody protein regulating abscission. Exp Cell Res 2011, 317(2):8.
5. Deckbar D, Stiff T, Koch B, Reis C, Lobrich M, Jeggo PA. The limitations of the G1-S checkpoint. Cancer Res 70(11):4412-4421.
6. Freiberg RA, Krieg AJ, Giaccia AJ, Hammond EM. Checking in on hypoxia/reoxygenation. Cell Cycle 2006, 5(12):1304-1307. 10.4161/cc.5.12.2811, 16760660.
7. Mavrogonatou E, Kletsas D. High osmolality activates the G1 and G2 cell cycle checkpoints and affects the DNA integrity of nucleus pulposus intervertebral disc cells triggering an enhanced DNA repair response. DNA Repair (Amst) 2009, 8(8):930-943.
8. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004, 73:39-85. 10.1146/annurev.biochem.73.011303.073723, 15189136.
9. Schnier JB, Nishi K, Harley WR, Gorin FA. An acidic environment changes cyclin D1 localization and alters colony forming ability in gliomas. J Neurooncol 2008, 89(1):19-26. 10.1007/s11060-008-9591-8, 2996278, 18404250.
10. Scicchitano DA, Mellon I. Transcription and DNA damage: a link to a kink. Environ Health Perspect 1997, 105(Suppl 1):145-153. 10.1289/ehp.97105s1145, 1470299, 9114283.
11. Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000, 16(4):168-174. 10.1016/S0168-9525(99)01971-X, 10729832.
12. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3(6):415-428.
13. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007, 128(4):683-692. 10.1016/j.cell.2007.01.029, 17320506.
14. Hallstrom TC, Nevins JR. Balancing the decision of cell proliferation and cell fate. Cell Cycle 2009, 8(4):532-535. 10.4161/cc.8.4.7609, 3018328, 19182518.
15. Paternot S, Bockstaele L, Bisteau X, Kooken H, Coulonval K, Roger PP. Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase. Cell Cycle 9(4):689-699.
16. Polager S, Ginsberg D. p53 and E2f: partners in life and death. Nat Rev Cancer 2009, 9(10):738-748. 10.1038/nrc2718, 19776743.
17. Poznic M. Retinoblastoma protein: a central processing unit. J Biosci 2009, 34(2):305-312. 10.1007/s12038-009-0034-2, 19550046.
18. Blain SW. Switching cyclin D-Cdk4 kinase activity on and off. Cell Cycle 2008, 7(7):892-898. 10.4161/cc.7.7.5637, 18414028.
19. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009, 9(3):153-166. 10.1038/nrc2602, 19238148.
20. Sullivan M, Morgan DO. Finishing mitosis, one step at a time. Nat Rev Mol Cell Biol 2007, 8(11):894-903. 10.1038/nrm2276, 17912263.
21. Del Sal G, Ruaro ME, Philipson L, Schneider C. The growth arrest-specific gene, gas1, is involved in growth suppression. Cell 1992, 70(4):595-607. 10.1016/0092-8674(92)90429-G, 1505026.
22. Evdokiou A, Cowled PA. Tumor-suppressive activity of the growth arrest-specific gene GAS1 in human tumor cell lines. Int J Cancer 1998, 75(4):568-577. 10.1002/(SICI)1097-0215(19980209)75:4<568::AID-IJC13>3.0.CO;2-5, 9466658.
23. Ouellet S, Vigneault F, Lessard M, Leclerc S, Drouin R, Guerin SL. Transcriptional regulation of the cyclin-dependent kinase inhibitor 1A (p21) gene by NFI in proliferating human cells. Nucleic Acids Res 2006, 34(22):6472-6487. 10.1093/nar/gkl861, 1702497, 17130157.
24. Uhrbom L, Holland EC. Modeling gliomagenesis with somatic cell gene transfer using retroviral vectors. J Neurooncol 2001, 53(3):297-305. 10.1023/A:1012208314436, 11718262.
25. Jenuwein T, Allis CD. Translating the histone code. Science 2001, 293(5532):1074-1080. 10.1126/science.1063127, 11498575.
26. Strahl BD, Allis CD. The language of covalent histone modifications. Nature 2000, 403(6765):41-45. 10.1038/47412, 10638745.
27. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A, Koeppen S, et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005, 122(6):957-968. 10.1016/j.cell.2005.08.029, 16169070.
28. Rice JC, Briggs SD, Ueberheide B, Barber CM, Shabanowitz J, Hunt DF, Shinkai Y, Allis CD. Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol Cell 2003, 12(6):1591-1598. 10.1016/S1097-2765(03)00479-9, 14690610.
29. Hagerstrand D, Hesselager G, Achterberg S, Wickenberg Bolin U, Kowanetz M, Kastemar M, Heldin CH, Isaksson A, Nister M, Ostman A. Characterization of an imatinib-sensitive subset of high-grade human glioma cultures. Oncogene 2006, 25(35):4913-4922. 10.1038/sj.onc.1209497, 16547494.
30. Vindelov LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983, 3(5):323-327. 10.1002/cyto.990030503, 6188586.
31. Roswall P, Bu S, Rubin K, Landstrom M, Heldin NE. 2-methoxyestradiol induces apoptosis in cultured human anaplastic thyroid carcinoma cells. Thyroid 2006, 16(2):143-150. 10.1089/thy.2006.16.143, 16676399.
32. Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, Holland EC. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 2001, 15(15):1913-1925. 10.1101/gad.903001, 312748, 11485986.
33. Tchougounova E, Kastemar M, Brasater D, Holland EC, Westermark B, Uhrbom L. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma. Oncogene 2007, 26(43):6289-6296. 10.1038/sj.onc.1210455, 17438529.